LWAM
CLB icon

Legacy Wealth Asset Management’s Core Laboratories CLB Stock Holding History

Legacy Wealth Asset Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,425
Closed -$490K – 342
2023
Q3 		$490K Sell
20,425
-2,606
-11% -$64K 0.18% 201
2023
Q2 		$535K Buy
23,031
+53
+0.2% +$1.2K 0.19% 191
2023
Q1 		$507K Buy
22,978
+154
+0.7% +$3.6K 0.18% 189
2022
Q4 		$463K Buy
+22,824
New +$442K 0.18% 197

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Legacy Wealth Asset Management's CLB Position: Q4 2023 in Review

Legacy Wealth Asset Management sold out of Core Laboratories (CLB) in Q4 2023, closing a stake of 20,425 shares — an estimated $490K sold.

Legacy Wealth Asset Management first reported a position in CLB in Q4 2022 and held it in 4 quarters. The position peaked at $535K in Q2 2023. 186 funds tracked by Wall St. Rank hold CLB as of Q4 2023.

  • Legacy Wealth Asset Management reported no remaining Core Laboratories position as of Q4 2023 after selling out during the quarter.
  • Legacy Wealth Asset Management sold 20,425 Core Laboratories shares in Q4 2023, an estimated $490K.
  • Legacy Wealth Asset Management first reported a position in Core Laboratories in Q4 2022 and held it in 4 quarters.
  • Legacy Wealth Asset Management's Core Laboratories position peaked at $535K in Q2 2023.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2023.

Based on Legacy Wealth Asset Management's 13F filing for Q4 2023, filed 10 Jan 2024.